Skip to main content
. 2019 Feb 28;97(4):563–577. doi: 10.1007/s00109-019-01747-3

Fig. 4.

Fig. 4

The effect of AAT (2–8 mg/ml) on primary human hepatocyte viability and function over a 4-day period. a Cell viability assessed using MTT assay. b Albumin production measured by ELISA. c Ureagenesis of hepatocytes treated with AAT measured using a QuantiChrome Urea assay. N = 3, N.S.